科伦药业：2025年度第二期科技创新债券发行结果的公告

Group 1 - The core point of the article is that Kelun Pharmaceutical announced the issuance of its second phase of technology innovation bonds for the year 2025, which took place on September 11, 2025, and the funds were fully received on September 12, 2025 [2] Group 2 - The company successfully raised funds through the bond issuance, indicating a positive step towards financing its technological innovations [2] - The announcement reflects the company's ongoing commitment to enhancing its research and development capabilities through financial instruments [2] - The timing of the bond issuance suggests strategic planning by the company to secure funding for future projects [2]